2020-2027 Analysis and Review Cardioverter Defibrillator Devices Market

Cardioverter Defibrillator Devices Market

Cardioverter Defibrillator Devices Market By Type (Implantable Cardioverter Defibrillator and External Cardioverter Defibrillator), By End Users (Hospital & Clinics, Ambulatory Surgical Centers and Others - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

16-06-2020 REP-HC-5118 40 Tables 110 pages Format

The cardioverter defibrillator devices market was valued at USD 9,031.3 Mn by 2019. Rising prevalence of cardiac complications worldwide associated with cardiac arrhythmias primarily drives the market growth. According to the latest research citings presented by the National Institute for Health (NIH), in the last 20 years, the number of cases associated with atrial fibrillation has increased by almost 33% throughout the globe.

Cardioverter Defibrillator Devices Market

Cardioverter defibrillator devices are employed for saving the lives of patients who are at a high risk of suffering from ventricular tachycardia. In this condition, the heart chambers are unable to contract which causes cardiac arrest within a few minutes eventually leading to sudden cardiac arrest. Technological advancement in the cardioverter defibrillator devices will drastically reduce the mortality rate associated with cardiac disorders.

The major segments related to the cardioverter defibrillator devices market are: 

By Type (2017–2027; US$ Mn)

Implantable Cardioverter Defibrillator

External Cardioverter Defibrillator

By End Users (2017–2027; US$ Mn)

Hospital & Clinics

Ambulatory Surgical Centers

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global cardioverter defibrillator devices market
  • The overall segmentation of the cardioverter defibrillator devices market, by type, end-users and geography are minutely studied. Implantable cardioverter defibrillator and hospitals & clinics are dominating the type and end-user segments respectively
  • Rising prevalence of cardiovascular complications worldwide
  • Technological advancement in the external cardioverter defibrillator further accentuates the market growth

Report gist?

  • The study of the global cardioverter defibrillator devices market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers a qualitative and quantitative analysis of the overall market segmented on the basis of type and end-users and categorization of the same at geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the medical device manufacturers actively engaged in the production and marketing of cardioverter defibrillator devices owing to the rising prevalence of cardiovascular complications worldwide
  • The report will benefit engineers engaged in the technological advancement of external cardioverter defibrillator devices
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to cardioverter defibrillator devices market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Implantable cardioverter defibrillator is representing the largest market share in the type segment for cardioverter defibrillator devices market. According to the recent statistics provided by the World Health Organization (WHO), sudden cardiac death and arrhythmias are responsible for 15 to 20% of all known deaths throughout the globe. The ergonomic features associated with its market dominance are a miniaturization of devices, simplified implantation procedure, and elimination of the leads implanted in the veins or the heart. Over the years the global healthcare regulatory authorities have expedited their early CE approval process and certified them as MRI safe. External cardioverter defibrillator devices are going to register rampant market growth during the forecast period due to its diverse mode of function such as manual and automated. They are widely employed for the resuscitation purpose in cases of sudden cardiac arrest, additionally, advancement in the operating software and mitigating the risk of infections associated with implantable devices has increased its popularity amongst the cardiologist worldwide.

Hospitals & clinics are presently leading the end-user segment for cardioverter defibrillator devices market. Significant increase in the number of inpatients admission in primary healthcare centers across the globe to undergo a surgical procedure for the implantable cardioverter defibrillator devices. Ambulatory surgical centers are expected to register exemplary market growth in the near future on account of the increasing demand for minimally invasive surgical procedures and government initiatives to promote ASC’s to reduce the healthcare cost burden associated with hospitals and clinics worldwide.

North America is currently dominating the geography segment for the cardioverter defibrillator devices market. The rising prevalence of cardiovascular complications in the adult population primarily drives market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 30.3 million adults in the United States are diagnosed with heart disease. Domicile of key players such as Boston Scientific Corporation, Medtronic, Plc., Abbott Laboratories, Inc., Cardiac Science Corporation, etc. further accelerates the market growth in the region. Europe is placed in the second position owing to the growing incidence of cardiac arrhythmias in the geriatric population in the region. The Asia Pacific is anticipated to be the fastest-growing segment in the regional segment for the cardioverter defibrillator devices market. Increasing medical tourism and developing healthcare infrastructure together determine the market growth in the Asia Pacific region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.